...
首页> 外文期刊>Srpski Arhiv za Celokupno Lekarstvo >Clinicopathological characteristics of Barrett's carcinoma, cardia carcinoma type II and distal gastric carcinoma: Influence of observed parameters on the five-year postoperative survival of patients
【24h】

Clinicopathological characteristics of Barrett's carcinoma, cardia carcinoma type II and distal gastric carcinoma: Influence of observed parameters on the five-year postoperative survival of patients

机译:Barrett癌,II型card门癌和远端胃癌的临床病理特征:观察参数对患者五年术后生存的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction. In the past two decades, the increased frequency of distal esophageal adenocarcinoma, esophagogastric junction and proximal gastric adenocarcinoma has been observed. The vast majority of these tumours are diagnosed in advanced stages, when the prognosis is poorer than in other gastric cancers. Objective. The aim of our study was to analyze the demographic and clinicopathological characteristics of patients operated on for Barrett's, cardia and distal gastric adenocarcinomas, as well as to study the influence of manifestations of each cancerogenetic indication on the studied clinicopathological parameters and to analyze the 5-year survival rate of patients surgically treated for cardia adenocarcinoma in relation to the patients operated on for distal gastric adenocarcinoma. Methods. We analyzed gender and age, tumour type, depth of tumour invasion, involvement of blood and lymph vessels in 66 patients surgically treated at the Centre for Oesophageal Surgery of the Institute for Digestive Diseases of the Belgrade Clinical Centre. Results. Except for significant differences in the depth of tumour invasion during surgery, there were no other statistically significant differences between the studied groups of patients. In the patients operated on for Barrett's and cardia cancers, the tumours invaded more deeply the wall layers, i.e. they were significantly more invasive than the distal gastric tumour. The lymph node involvement was present in 87.5% of patients with Barrett's cancer, in 80% with cardia cancer and in 87% with distal gastric cancer. The 3-year survival rate of patients operated on for cardia cancer was 47.4% and the 5-year survival rate was 31.6%, while the 3-year survival rate of patients operated on for distal gastric cancer was 46.2% and the 5-year survival rate was 34.6%. These differences were not statistically significant (Wilcoxon 0,036; p=0,85). Singly, the patients' gender, cancer type and the degree of tumour differentiation had no influence on the length of patients' postsurgical survival rate. Conclusion. At the time of diagnosis cardia cancer and cancers developed at the location of the Barrett's oesophagus, developed significant deeper per continuitatem than gastric cancer. There were no other differences in regard to the analyzed clinicopathological parameters among the tumours of these three locations, and there was no difference between the 3-year and 5-year survival rate between the patients operated on for gastric cancer and cardia cancer. Each studied clinicopathological parameter had no influence on the illness course.
机译:介绍。在过去的二十年中,已经发现远端食管腺癌,食管胃交界处和近端胃腺癌的发生率增加。当预后比其他胃癌差时,这些肿瘤中的绝大多数被诊断为晚期。目的。我们的研究目的是分析接受Barrett,card门癌和远端胃腺癌手术的患者的人口统计学和临床​​病理特征,以及研究每种致癌指征对所研究的临床病理学参数的影响并分析5 card门腺癌手术患者相对于远端胃腺癌手术患者的一年生存率。方法。我们分析了贝尔格莱德临床中心消化疾病研究所食管外科中心手术治疗的66名患者的性别和年龄,肿瘤类型,肿瘤浸润深度,血管和淋巴管受累情况。结果。除了手术期间肿瘤浸润深度的显着差异外,研究组患者之间没有其他统计学上的显着差异。在接受Barrett和card门癌手术的患者中,肿瘤浸润到壁层的深度更深,即,与远端胃癌相比,其浸润性明显更高。淋巴结受累的患者中,巴雷特癌症患者占87.5%,card门癌患者占80%,远端胃癌患者占87%。接受card门癌手术的患者的3年生存率是47.4%,5年生存率是31.6%,而接受远端胃癌手术的3年生存率是46.2%,5年生存率生存率为34.6%。这些差异无统计学意义(Wilcoxon 0,036; p = 0.85)。单独地,患者的性别,癌症类型和肿瘤分化程度对患者术后生存时间的长短没有影响。结论。在诊断时,card门癌和巴雷特氏食管部位发生的癌症比胃癌的每个连续病变更深。在这三个部位的肿瘤之间,在分析的临床病理参数方面没有其他差异,并且接受胃癌和card门癌手术的患者的3年生存率和5年生存率也没有差异。每个研究的临床病理参数对病程没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号